Zelig Eshhar

Weizmann Institute of Science, Rehovot, Israel 
Oncology, Cell Biology, Genetics
"Zelig Eshhar"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Globerson Levin A, Rawet Slobodkin M, Waks T, et al. (2020) Treatment of Multiple Myeloma using Chimeric Antigen Receptor T Cells with Dual Specificity. Cancer Immunology Research
Szoor A, Toth G, Zsebik B, et al. (2020) Trastuzumab derived HER2-specific CARs for the treatment of trastuzumab-resistant breast cancer: CAR T cells penetrate and eradicate tumors that are not accessible to antibodies. Cancer Letters
Globerson Levin A, Kronik N, Shiloach T, et al. (2020) Less is more: reducing the number of administered chimeric antigen receptor T cells in a mouse model using a mathematically guided approach. Cancer Immunology, Immunotherapy : Cii
Zupančič E, Curato C, Kim JS, et al. (2018) Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine
Blat D, Zigmond E, Alteber Z, et al. (2014) Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1018-28
Eshhar Z, Waks T, Gross G. (2014) The emergence of T-Bodies/CAR T cells Cancer Journal (United States). 20: 123-126
Globerson-Levin A, Waks T, Eshhar Z. (2014) Elimination of progressive mammary cancer by repeated administrations of chimeric antigen receptor-modified T cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1029-38
Friedmann-Morvinski D, Waks T, Marcus A, et al. (2014) Adoptive Cell Therapy of Systemic Metastases Using erbB-2-Specific T Cells Redirected with a Chimeric Antibody-Based Receptor Current Cancer Research. 12: 107-122
Chmielewski M, Maliar A, Eshhar Z, et al. (2012) CAR's made it to the pancreas. Oncoimmunology. 1: 1387-1389
Fishler R, Artzy-Schnirman A, Peer E, et al. (2012) Mixed alkanethiol monolayers on submicrometric gold patterns: a controlled platform for studying cell-ligand interactions. Nano Letters. 12: 4992-6
See more...